Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Kay

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Human Gene Therapy|August 1, 1993
Assessment of recombinant adenoviral vectors for hepatic gene therapyQ Li, M A Kay, M Finegold, et al.
Gene Therapy|April 1, 1997
Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivoD B Schowalter, J C Tubb, M Liu, et al.
Gene Therapy|August 1, 1997
Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expressionD B Schowalter, L Meuse, C B Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 1995
Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivoA Lieber, M J Vrancken Peeters, L Meuse, et al.
Cancer Gene Therapy|January 1, 1997
Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectorsK Brand, W Arnold, T Bartels, et al.
Journal of Virology|July 4, 2001
Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivoH Nakai, S R Yant, T A Storm, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993
Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complexR J Cristiano, L C Smith, M A Kay, et al.
Journal of Virology|May 11, 1999
Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent miceD B Schowalter, C L Himeda, B L Winther, et al.
Gene Therapy|June 15, 2001
A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knobH Mizuguchi, N Koizumi, T Hosono, et al.
Cold Spring Harbor Symposia on Quantitative Biology|July 28, 2006
Genomic progression in mouse models for liver tumorsA D Tward, K D Jones, S Yant, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Human Gene Therapy|August 1, 1993
Assessment of recombinant adenoviral vectors for hepatic gene therapyQ Li, M A Kay, M Finegold, et al.
Gene Therapy|April 1, 1997
Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivoD B Schowalter, J C Tubb, M Liu, et al.
Gene Therapy|August 1, 1997
Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expressionD B Schowalter, L Meuse, C B Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 1995
Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivoA Lieber, M J Vrancken Peeters, L Meuse, et al.
Cancer Gene Therapy|January 1, 1997
Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectorsK Brand, W Arnold, T Bartels, et al.
Journal of Virology|July 4, 2001
Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivoH Nakai, S R Yant, T A Storm, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993
Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complexR J Cristiano, L C Smith, M A Kay, et al.
Journal of Virology|May 11, 1999
Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent miceD B Schowalter, C L Himeda, B L Winther, et al.
Gene Therapy|June 15, 2001
A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knobH Mizuguchi, N Koizumi, T Hosono, et al.
Cold Spring Harbor Symposia on Quantitative Biology|July 28, 2006
Genomic progression in mouse models for liver tumorsA D Tward, K D Jones, S Yant, et al.
Pageof 11